Patents by Inventor Kenneth Brooks

Kenneth Brooks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11832989
    Abstract: A compression assembly is coupled to the gantry of an ultrasound breast imaging system. The compression assembly includes a pair of compression paddles mounted on a positioning track, Each compression paddle houses a transducer and has a compression material surface for patient contact. A motor moves the compression paddles along the positioning track to immobilize the breast for ultrasound imaging.
    Type: Grant
    Filed: June 21, 2019
    Date of Patent: December 5, 2023
    Assignee: Hologic, Inc.
    Inventors: Kenneth F. Defreitas, Ian Shaw, Kenneth Brooks, Jay A. Stein
  • Publication number: 20150336722
    Abstract: The present invention relates to closure arrangements for liquid containers, particularly but not exclusively for drinks bottles. A closure arrangement (20) for a liquid container for a base liquid comprises a reservoir (24A, 24B) for an additive liquid (28A, 28B). The closure arrangement (20) comprises a passage (54) for flow of liquid from the base liquid container (11) to a user, the passage including a mixing space (26) for mixing the additive liquid from the reservoir and the base liquid. The present invention further relates to a liquid container assembly including a closure arrangement. The present invention further relates to an additive reservoir for use in a closure arrangement.
    Type: Application
    Filed: December 13, 2013
    Publication date: November 26, 2015
    Inventors: Samantha Claire BROOK-CHRISPIN, Kenneth BROOK-CHRISPIN, Jon MASON
  • Patent number: 8964936
    Abstract: System, apparatus and methods specialized for breast and related tissue radiation therapy and imaging of a prone patient but also usable for supine patient if desired or needed. A special treatment radiation source such as a LINAC unit generates radiation of types and energy ranges specifically matched to breast tissue. Any one or more of several imaging technologies may be used to localize the tissue to be irradiated and to generate information for therapy planning, adjustment, and verification.
    Type: Grant
    Filed: July 25, 2012
    Date of Patent: February 24, 2015
    Assignee: Hologic, Inc.
    Inventors: Kenneth Brooks, Jay A. Stein, Andrew P. Smith
  • Patent number: 8254521
    Abstract: System, apparatus and methods specialized for breast and related tissue radiation therapy and imaging of a prone patient but also usable for supine patient if desired or needed. A special treatment radiation source such as a LINAC unit generates radiation of types and energy ranges specifically matched to breast tissue. Any one or more of several imaging technologies may be used to localize the tissue to be irradiated and to generate information for therapy planning, adjustment, and verification.
    Type: Grant
    Filed: May 17, 2011
    Date of Patent: August 28, 2012
    Assignee: Hologic, Inc.
    Inventors: Kenneth Brooks, Jay A. Stein, Andrew P. Smith
  • Patent number: 7957508
    Abstract: System, apparatus and methods specialized for breast and related tissue radiation therapy and imaging of a prone patient but also usable for supine patient if desired or needed. A special treatment radiation source such as a LINAC unit generates radiation of types and energy ranges specifically matched to breast tissue. Any one or more of several imaging technologies may be used to localize the tissue to be irradiated and to generate information for therapy planning, adjustment, and verification.
    Type: Grant
    Filed: November 21, 2007
    Date of Patent: June 7, 2011
    Assignee: Hologic, Inc.
    Inventors: Kenneth Brooks, Jay A. Stein, Andrew P. Smith
  • Patent number: 7514089
    Abstract: The present invention is directed to mutant Salmonella sp. having a genetically modified msbB gene in which the mutant Salmonella is capable of targeting solid tumors. The present invention further relates to the therapeutic use of the mutant Salmonella for growth inhibition and/or reduction in volume of solid tumors.
    Type: Grant
    Filed: April 28, 2005
    Date of Patent: April 7, 2009
    Assignee: Vion Pharmaceuticals, Inc.
    Inventors: David Bermudes, Kenneth Brooks Low
  • Publication number: 20090080602
    Abstract: System, apparatus and methods specialized for breast and related tissue radiation therapy and imaging of a prone patient but also usable for supine patient if desired or needed. A special treatment radiation source such as a LINAC unit generates radiation of types and energy ranges specifically matched to breast tissue. Any one or more of several imaging technologies may be used to localize the tissue to be irradiated and to generate information for therapy planning, adjustment, and verification.
    Type: Application
    Filed: September 24, 2007
    Publication date: March 26, 2009
    Inventors: Kenneth Brooks, Jay A. Stein, Andrew P. Smith
  • Publication number: 20080307984
    Abstract: A debris compaction device for use with compressing leaves within a leaf disposal bag is disclosed. One or more handles are provided on the top side of the debris compaction device to facilitate the compaction process. Air vents facilitate the channeling of air during the compaction process.
    Type: Application
    Filed: June 13, 2007
    Publication date: December 18, 2008
    Inventor: Kenneth Brooks
  • Patent number: 7354592
    Abstract: The present invention is directed to mutant Salmonella sp. having a genetically modified msbB gene in which the mutant Salmonella is capable of targeting solid tumors. The invention is also directed to Salmonella sp. containing a genetically modified msbB gene as well as an genetic modification in a biosynthetic pathway gene such as the purl gene. The present invention further relates to the therapeutic use of the mutant Salmonella for growth inhibition and/or reduction in volume of solid tumors.
    Type: Grant
    Filed: February 23, 2005
    Date of Patent: April 8, 2008
    Assignees: Vion Pharmaceuticals, Inc., Yale University
    Inventors: David Bermudes, Kenneth Brooks Low
  • Publication number: 20060072705
    Abstract: An apparatus for modulating an intensity of a radiation beam includes a filter having a cross sectional shape such that a radiation beam filtered therethrough and passed through a patient will have an intensity that is substantially non-uniform. An apparatus for modulating an intensity of a radiation beam generated by a radiation source includes a filter, and a positioner secured to the filter, the positioner configured to move the filter relative to the radiation source.
    Type: Application
    Filed: October 1, 2004
    Publication date: April 6, 2006
    Applicant: Varian Medical Systems Technologies, Inc.
    Inventors: Peter Munro, Kenneth Brooks
  • Patent number: 6923972
    Abstract: The present invention is directed to mutant Salmonella sp. having a genetically modified msbB gene in which the mutant Salmonella is capable of targeting solid tumors. The present invention further relates to the therapeutic use of the mutant Salmonella for growth inhibition and/or reduction in volume of solid tumors.
    Type: Grant
    Filed: April 18, 2002
    Date of Patent: August 2, 2005
    Assignees: Vion Pharmaceuticals, Inc., Yale University
    Inventors: David Bermudes, Kenneth Brooks Low
  • Patent number: 6863894
    Abstract: The present invention is directed to mutant Salmonella sp. having a genetically modified msbB gene in which the mutant Salmonella is capable of targeting solid tumors. The invention is also directed to Salmonella sp. containing a genetically modified msbB gene as well as an genetic modification in a biosynthetic pathway gene such as the purI gene. The present invention further relates to the therapeutic use of the mutant Salmonella for growth inhibition and/or reduction in volume of solid tumors.
    Type: Grant
    Filed: June 27, 2002
    Date of Patent: March 8, 2005
    Assignees: Vion Pharmaceuticals, Inc., Yale University
    Inventors: David Bermudes, Kenneth Brooks Low
  • Patent number: 6685935
    Abstract: The present invention is directed to the isolation and use of super-infective, tumor-specific vectors that are strains of parasites including, but not limited to bacteria, fungi and protists. In certain embodiments the parasites include, but are not limited to, the bacterium Salmonella spp., such as Salmonella typhimurium, the bacterium Mycobacterium avium and the protozoan Leishmania amazonensis. In other embodiments, the present invention is concerned with the isolation of super-infective, tumor-specific, suicide gene-containing strains of parasites for use in treatment of solid tumors.
    Type: Grant
    Filed: July 21, 1999
    Date of Patent: February 3, 2004
    Assignee: Yale University
    Inventors: John M. Pawelek, David Bermudes, Kenneth Brooks Low
  • Publication number: 20030170276
    Abstract: The present invention is directed to mutant Salmonella sp. having a genetically modified msbB gene in which the mutant Salmonella is capable of targeting solid tumors. The present invention further relates to the therapeutic use of the mutant Salmonella for growth inhibition and/or reduction in volume of solid tumors.
    Type: Application
    Filed: April 18, 2002
    Publication date: September 11, 2003
    Applicant: Vion Pharmaceuticals, Inc.
    Inventors: David Bermudes, Kenneth Brooks Low
  • Publication number: 20030109026
    Abstract: The present invention is directed to mutant Salmonella sp. having a genetically modified msbB gene in which the mutant Salmonella is capable of targeting solid tumors. The invention is also directed to Salmonella sp. containing a genetically modified msbB gene as well as an genetic modification in a biosynthetic pathway gene such as the purI gene. The present invention further relates to the therapeutic use of the mutant Salmonella for growth inhibition and/or reduction in volume of solid tumors.
    Type: Application
    Filed: June 27, 2002
    Publication date: June 12, 2003
    Applicant: Vion Pharmaceuticals, Inc.
    Inventors: David Bermudes, Kenneth Brooks Low
  • Patent number: 6475482
    Abstract: The invention is directed to mutant Salmonella sp. having a genetically modified msbB gene in which the mutant Salmonella is capable of targeting solid tumors. The invention further relates to the therapeutic use of the mutant Salmonella for growth inhibition and/or reduction in volume of solid tumors.
    Type: Grant
    Filed: June 22, 1999
    Date of Patent: November 5, 2002
    Assignee: Vion Pharmaceuticals, Inc.
    Inventors: David Bermudes, Kenneth Brooks Low
  • Patent number: 6447784
    Abstract: The present invention is directed to mutant Salmonella sp. having a genetically modified msbB gene in which the mutant Salmonella is capable of targeting solid tumors. The invention is also directed to Salmonella sp. containing a genetically modified msbB gene as well as an genetic modification in a biosynthetic pathway gene such as the purI gene. The present invention further relates to the therapeutic use of the mutant Salmonella for growth inhibition and/or reduction in volume of solid tumors.
    Type: Grant
    Filed: September 8, 1998
    Date of Patent: September 10, 2002
    Assignees: Vion Pharmaceuticals, Inc., Yale University
    Inventors: David Bermudes, Kenneth Brooks Low
  • Patent number: 6190657
    Abstract: The present invention is directed to the isolation and use of super-infective, tumor-specific vectors that are strains of parasites including, but not limited to bacteria, fungi and protists. In certain embodiments the parasites include, but are not limited to, the bacterium Salmonella spp., such as Salmonella typhimurium, the bacterium Mycobacterium avium and the protozoan Leishmania amazonensis. In other embodiments, the present invention is concerned with the isolation of super-infective, tumor-specific, suicide gene-containing strains of parasites for use in treatment of solid tumors.
    Type: Grant
    Filed: June 4, 1996
    Date of Patent: February 20, 2001
    Assignee: Yale University
    Inventors: John M. Pawelek, David Bermudes, Kenneth Brooks Low
  • Patent number: 6080849
    Abstract: The present invention is directed to mutant Salmonella sp. having a genetically modified msbB gene in which the mutant Salmonella is capable of targeting solid tumors. The present invention further relates to the therapeutic use of the mutant Salmonella for growth inhibition and/or reduction in volume of solid tumors.
    Type: Grant
    Filed: September 10, 1997
    Date of Patent: June 27, 2000
    Assignees: Vion Pharmaceuticals, Inc., Yale University
    Inventors: David Bermudes, Kenneth Brooks Low
  • Patent number: 4649972
    Abstract: Method and apparatus for crimping a round tenon for furniture manufacture, utilizing a crimping roll cluster consisting of a knurled drive roll and two idler compressing rolls. The apparatus includes means for feeding a wooden workpiece into and out of axial alignment with the crimping roll cluster; means for pressing the wooden workpiece into engagement with the knurled portion of the drive roll; means for rotating the workpiece from one to two revolutions, thus forming flutes into the tenon; and means for discharging the workpiece from the apparatus.Also disclosed is a method and apparatus for fluting a workpiece having tenons on both ends.
    Type: Grant
    Filed: November 7, 1985
    Date of Patent: March 17, 1987
    Assignee: York Industries, Inc.
    Inventor: Kenneth Brooks